作者: Jonathan Morton , Justin Davies
DOI: 10.1007/978-3-319-55957-5_9
关键词:
摘要: Anal cancer is rare. Surgery was once first line treatment however chemoradiotherapy has now replaced this with radical surgery being reserved for less than 10% of patients. The incidence anal on the rise, suggesting that again, condition will become more frequent. With many types described and misdiagnosed as benign conditions by both specialists primary care practitioners it important to have an understanding these conditions. This chapter examine epidemiology, diagnostic challenges dilemmas confront members multidisciplinary teams when treating